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Abstract
Background
Chagas disease (CD) is a major public health concern in Latin America and a potentially
serious emerging threat in non-endemic countries. Although the association between CD
and cardiac abnormalities is widely reported, study design diversity, sample size and quality
challenge the information, calling for its update and synthesis, which would be very useful
and relevant for physicians in non-endemic countries where health care implications of CD
are real and neglected. We performed to systematically review and meta-analyze popula-
tion-based studies that compared prevalence of overall and specific ECG abnormalities
between CD and non-CD participants in the general population.
Methods
Six databases (EMBASE, Ovid Medline, Web of Science, Cochrane Central, Google
Scholar and Lilacs) were searched systematically. Observational studies were included.
Odds ratios (OR) were computed using random-effects model.
Results
Forty-nine studies were selected, including 34,023(12,276 CD and 21,747 non-CD). Preva-
lence of overall ECG abnormalities was higher in participants with CD (40.1%; 95%
CIs=39.2-41.0) compared to non-CD (24.1%; 95%CIs=23.5-24.7) (OR=2.78; 95%
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CIs=2.37-3.26). Among specific ECG abnormalities, prevalence of complete right bundle
branch block (RBBB) (OR=4.60; 95%CIs=2.97-7.11), left anterior fascicular block (LAFB)
(OR=1.60; 95%CIs=1.21-2.13), combination of complete RBBB/LAFB (OR=3.34; 95%
CIs=1.76-6.35), first-degree atrioventricular block (A-V B) (OR=1.71; 95%CIs=1.25-2.33),
atrial fibrillation (AF) or flutter (OR=2.11; 95%CIs=1.40-3.19) and ventricular extrasystoles
(VE) (OR=1.62; 95%CIs=1.14-2.30) was higher in CD compared to non-CD participants.
Conclusions
This systematic review and meta-analysis provides an update and synthesis in this field.
This research of observational studies indicates a significant excess in prevalence of ECG
abnormalities (40.1%) related to T. cruzi infection in the general population from Chagas
endemic regions, being the most common ventricular (RBBB and LAFB), and A-V B (first-
degree) node conduction abnormalities as well as arrhythmias (AF or flutter and VE). Also,
prevalence of ECG alterations in children was similar to that in adults and suggests earlier
onset of cardiac disease.
Author summary
Chagas disease (CD) is a major public health concern in Latin America and a potentially
serious emerging threat in non-endemic countries. Although the association between CD
and cardiac abnormalities is widely reported, study design diversity, sample size and qual-
ity challenge the information, calling for its update and synthesis, which would be very
useful and relevant for physicians in non-endemic countries where health care implica-
tions of CD are real and neglected. We systematically reviewed and meta-analyzed popu-
lation-based studies that compared prevalence of ECG abnormalities between Chagas
disease (CD) and non-CD participants. Forty-nine studies were selected, including 34,023
unique participants. Our meta-analysis of observational studies indicates CD presented
almost a threefold increase prevalence of ECG abnormalities than non-CD participants in
the general population from Chagas endemic regions, being the most common ventricular
(RBBB and LAFB), and A-V B (first-degree) node conduction abnormalities as well as
arrhythmias (AF or flutter and VE).
Introduction
Chagas disease (CD), is caused by the protozoan Trypanosoma cruzi[1]. It affects individuals
from more than 21 countries, being a major public health concern in Latin Americas and a
potentially serious emerging threat to a number of non-endemic countries[2]. In Latin Ameri-
can countries, there are currently 8-10 million people having CD, with an additional 300,000
individuals in the United States and 45,000-67,000 in Europe[3–6].
Infection with T. cruzi has two phases: acute and chronic, separated by an indeterminate
period, in which the patient is relatively asymptomatic[7, 8]. Chronically infected patients ulti-
mately develop cardiomyopathy, which is the most important and severe manifestation of CD,
and is characterized by left ventricular systolic dysfunction, wall motion abnormalities, brady
and tachyarrhythmia, heart failure and sudden cardiac death[9–18]. CD alterations are classi-
fied in four stages A, B, C, and D. Stage A corresponds to asymptomatic patients with normal
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ECG, whereas presence of electrocardiographic abnormalities implies progression towards
stage B and deterioration of systolic function is observed in stages C/D, associated with heart
failure symptoms. Of note, sudden cardiac death may occur at any moment, including early
phases[10, 16].
The association between CD and cardiac abnormalities (stages B or more) is widely
reported, however, the information is challenged by the diverse design, sample size and quality
of the studies[19–24]. This information is largely based on outdated individual studies, and
reports vary substantially among the population based studies making the scientific interpreta-
tion challenging[8, 20, 25–28]. Furthermore, it is known that the prevalence of different types
of ECG abnormalities such as intraventricular conduction abnormalities, atrioventricular
block, and arrhythmias, is higher in subjects with CD as compared to non-CD subjects, calling
for its update and synthesis, which would be very useful and relevant for physicians in non-
endemic countries where health care implications of CD are real and neglected[29]. Given the
spread of CD, a need exists for an adequate, comprehensive assessment of CD in association
with ECG abnormalities[6, 29, 30].
We conducted a systematic review and meta-analysis to (i) determine the overall prevalence
of ECG abnormalities in seropositive and seronegative CD individuals in the general popula-
tion; (ii) quantify the prevalence of subtypes of ECG abnormalities in this population; and (iii)
characterize these estimates by age, sex and region of origin, and (iv) evaluate the discrimina-
tory capacity of ECG abnormalities, both general and specific to classify patients as either CD
or non-CD.
Methods
Data sources and search strategy
This review was conducted in accordance with MOOSE guideline[31] and, we followed the
protocol strictly without deviation from it. An extensive literature search of articles published
up to March 2017 was conducted with the assistance of a medical librarian in six electronic
databases (EMBASE, Ovid Medline, Web of Science, Cochrane Central, Google Scholar and
Lilacs) without any language restriction. Search combined terms related to CD (Chagas Dis-
ease, Trypanosoma cruzi), with terms related to seroepidemiology (Seroepidemiologic Studies,
Seroprevalence, Seroepidemiology) (S1 Appendix). Reference lists of selected studies and
reviews identified on the topic were searched to identify additional publications.
Study selection and eligibility criteria
Studies were eligible if they: (i) selected cases and controls from the general population (sur-
veys and blood donors); (ii) were cross-sectional, case-control and cohort studies; (iii) reported
CD status based on any techniques for the detection of antibodies; and (iv) reported the preva-
lence of ECG abnormalities in CD participants and non-CD participants, based on electrocar-
diographic diagnosis. To avoid overestimation of the effect estimates, we did not include
studies using cases and controls from a clinical setting. Two independent reviewers screened
the titles and abstracts of all initially identified studies according to the selection criteria. Full
texts were retrieved from studies that fulfilled all selection criteria. Any disagreements were
resolved through consensus or consultation with a third independent reviewer.
Data extraction
The data collection form included questions on qualitative aspects of the studies (such as
author, date of publication, country, design, period, setting, area and sample size), participant
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characteristics (such as age, sex and serological test of CD) and information on the reported
exposure/outcome (such as measure definition of ECG abnormalities, number of patients
seropositive/seronegative CD, number of patients with general and specific ECG abnormalities
and confounders adjustment). For cohort studies, only the information from the baseline
assessment was extracted.
Assessing the risk of bias
Study quality was assessed by two independent reviewers based on the nine-star Newcastle-
Ottawa Scale (NOS) using three predefined domains, namely: selection of participants (popu-
lation representativeness), comparability (adjustment for confounders) and ascertainment of
outcomes of interests[32]. The NOS assigns a maximum of four or five points for selection,
one or two points for comparability and three points for outcome, depending on study design
(cross-sectional or cohort). We used the NOS scale adapted for cross-sectional studies and the
NOS for case-control studies while for cohort studies we used the NOS for a cross-sectional
design (S2 Appendix). Studies that received a score of nine to seven stars were judged to be at
low risk of bias; studies that scored five or six stars were considered at medium risk, and those
that scored four or less were considered at high risk of bias.
Statistical analysis
Narrative synthesis and construction of descriptive summary tables were performed for the
studies included. For this meta-analysis, we used odds ratios (ORs) and 95% confidence inter-
vals (CIs), to assess the association between presence of CD, and overall and specific ECG
abnormalities. Also, we calculated the pooled prevalence (P) of ECG abnormalities for CD and
non-CD participants. The inverse variance weighted method was used to combine summary
measures using random-effects models to minimize the effect of between-study heterogeneity
[33]. Heterogeneity was assessed using the Cochrane χ2 statistic and the I2 statistic and was cat-
egorized as low (I225%), moderate (I2>25% and<75%), or high (I275%)[34]. Sensitivity
analyses were performed to assess the influence of study-level characteristics including publi-
cation year, geographical location (according to the number of study in each country and by
the prevalence of Trypanosoma cruzi genotype), design, area, number and age of participants,
sex, definition of ECG abnormalities, test for CD diagnoses, level of adjustment and risk of
bias, which were pre-specified as characteristics for assessment of heterogeneity and were eval-
uated using stratified analysis and random-effects meta-regression[35]. Publication bias was
evaluated through funnel plots and Egger’s regression symmetry tests[36]. All tests were
2-tailed; p-value0.05 was considered statistically significant. Stata release 15 (StataCorp) was
used for all analyses. Additionally, we evaluated the discriminatory capacity of ECG abnormal-
ities, both general and specific: sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV) to classify patients as either CD or non-CD.
Results
Study identification and selection
The database searches identified 5,396 citations. After screening the titles and abstracts, 252
articles were selected for detailed evaluation of full texts. Of these, 49 articles met our inclusion
criteria and were included in the review (Fig 1, S3 Appendix and S1–S3 Tables).
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General characteristics of included studies
General characteristics of included studies are shows in S1–S3 Tables summarize the key char-
acteristics of the included studies. Of 49 included studies, 43 were cross-sectional and 6 cohort
population-based studies and were published between 1964 and 2015. Studies were based on
data from 10 Latin America countries. The majority of studies was conducted in Brazil
(38.7%), collected data between 2001 and 2010 (34.6%), and included participants from rural
areas (44.9%). In aggregate, 34,023 participants (12,276 CD and 21,747 non-CD) were
Fig 1. PRISMA flow diagram of selection process of eligible studies. From a total of 5,396 eligible studies, and 49 were included in meta-analysis.
https://doi.org/10.1371/journal.pntd.0006567.g001
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included in this review. The age range of the participants was 0-97 years and 54.4% of partici-
pants were women (reported by 38 articles). The majority of studies (81.6%) used two or more
different diagnostic tests for T. cruzi infection.
Overall and specific ECG abnormalities
In the meta-analysis of 34,023 participants and 12,276 CD participants, overall ECG abnormal-
ities were significantly more prevalent in participants with CD (Prevalence (P)=40.1%; 95%
CIs=39.2-41.0) compared to those without CD (P=24.1%; 95%CIs=23.5-24.7) (OR=2.78; 95%
CIs=2.37-3.26) (Fig 2 and Table 1).
Up to 30 studies (range 3 to 30), based on 3,451 ± 1,350 participants, examined prevalence
of ventricular conduction defects in CD and non-CD participants (Table 2). In the pooled
analysis, prevalence of complete right bundle branch block (RBBB) (OR=4.60; 95%CIs=2.97-
7.11), left anterior fascicular block (LAFB) (OR=1.60; 95%CIs=1.21-2.13) and, the combina-
tion of complete RBBB and LAFB (OR=3.34, 95%CIs=1.76-6.35) was higher in CD partici-
pants compared to non-CD participants (Fig 3), while no difference in prevalence of
incomplete RBBB (OR=0.85; 95%CIs=0.63-1.16), incomplete left bundle branch block (LBBB)
(OR=0.63; 95%CIs=0.39-1.01), complete LBBB (OR=0.99; 95%CIs=0.62-1.58) and left poste-
rior fascicular block (LPFB) (OR=0.96, 95%CIs=0.35-2.62) was found between CD and non-
CD individuals (Table 2 and S1–S7 Figs). Prevalence of AV-B in CD and non-CD participants
was examined by 21 studies (range 5 to 21), including 4,438 ± 1,847 participants. Pooled preva-
lence first degree AV-B (OR=1.71; 95%CIs=1.25-2.33) was higher in CD participants com-
pared to non-CD (Fig 3), while no difference in prevalence of second-degree AV-B (OR=1.15;
95%CIs=0.33-4.06) and third-degree AV-B (OR=2.10; 95% CIs=0.60-7.34) was found between
CD and non-CD participants (Table 2 and S8–S10 Figs). Twenty-five studies (range 11 to 25
studies), based on 4,848 ± 1,591 participants, compared prevalence of arrhythmias between
CD and non-CD participants. Pooled prevalence of AF or flutter (OR=2.11, 95%CIs=1.40-
3.19) and ventricular extrasystoles (VE) (OR=1.62; 95%CIs=1.14-2.30) was higher in CD par-
ticipants (Table 2, Fig 3 and S11–S14 Figs). In a pooled analysis of 10 studies, comprising
5,575 individuals, no statistically significant difference in prevalence of other ECG abnormali-
ties (Low voltage QRS, OR=0.84; 95%CIs=0.47-1.50) was found between CD and non-CD
(Table 2 and S15 Fig).
Study quality and assessment of bias
Regarding of study quality and assessment bias, among the 49 included studies, 10 studies
were judged to be at low risk of bias, 28 were at medium risk, and 11 studies were evaluated to
be at high risk of bias (Table 1, S2 Appendix, S3 Table and S16 Fig).
Sensitivity analysis
In the sensitivity analysis, of 16 meta-analyses, while five showed no heterogeneity (I2=0,
p>0.05 for the Cochrane χ2 statistic), four showed low (I2=<25%), six moderate and one high
between-study heterogeneity, four of which with an I2 estimate exceeding 50% (overall ECG
abnormalities, complete RBBB, LAFB and VE) (Fig 2, Tables 1 and 2 and S4–S6 Tables). No
study characteristics could explain the heterogeneity observed in overall ECG abnormalities
(p-value of meta-regression0.05) (Table 1 and S17–S27 Figs). Additionally, S28 Fig shows
meta-analyses estimates of overall ECG abnormalities excluding single studies one by one,
with no evidence of change in the pooled. Similarly, the stratified analysis by sex and age,
although showed higher magnitudes of the association in children and men, the effects were
not significantly different between sex and age strata: higher OR was observed in children
Electrocardiographic (ECG) abnormalities in Chagas disease
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(OR=3.88; 95%CIs=1.69-8.88; I2=63.9%) compared with all ages or10 years categories; how-
ever, when a small-sample study was omitted, the OR of children was similar to that of the
other categories (OR=2.83; 95%CIs=2.26-3.53; I2=0.0%) without being statistically significant
in the meta-regression analysis (p-value of meta-regression=0.704), and comparison of overall
ECG abnormalities by sex, could be quantified only in a limited number of studies (12.2%)
(Table 1, S25, S26 and S29 Figs). For the studies on the association between CD, complete
RBBB, LAFB and VE, the identified heterogeneity was largely explained by geographic
Fig 2. Meta-analyses of overall ECG abnormalities in Chagas and Non-Chagas disease. The box are proportional to the weight of each study in the
analysis, and the lines represent their 95% confidence intervals (CIs). The open diamond represents the pooled odds ratio, and its width represents
it’s 95% CI. Abbreviations: CD=Chagas disease: CAs=ECG abnormalities.
https://doi.org/10.1371/journal.pntd.0006567.g002
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Table 1. Meta-analysis of overall ECG abnormalities in CD and Non-CD by characteristics of studies.
Characteristics Number of
studies
Pooled ECG Abnormalities Heterogeneity p-value Cochran’s
Q
p-value
Meta-
regression
Total
CD
CAs in
CD
Total Non-
CD
CAs in Non-
CD
OR (95% CI) I2 (%) p-value
Overall studies 49 12,276 4,922 21,747 5,243 2.78 (2.37-
3.26)
81.9 0.000 0.000 ——
Publication year
1964-1989 13 3,837 1,314 8,464 2,210 3.08 (2.12-
4.48)
89.3 0.000 0.000 0.480
1990-2000 12 1,649 618 3,389 528 3.10 (2.11-
4.57)
78.4 0.000
2001-2010 17 3,303 1,179 5,630 986 2.64 (2.08-
3.36)
68.6 0.000
2011-2015 7 3,487 1,811 4,264 1,519 2.07 (1.48-
2.90)
79.7 0.000
Location
Brazil 19 7,360 3,280 11,191 3,156 2.82 (2.30-
3.46)
81.8 0.000 0.000 0.065
Mexico 7 360 127 690 77 4.12 (1.71-
9.91)
76.6 0.000
Bolivia 6 943 357 2,340 571 2.28 (1.42-
3.66)
73.6 0.002
Argentina 6 891 306 2,867 762 2.24 (1.22-
4.12)
88.0 0.000
Colombia 3 781 195 1,958 277 1.63 (1.30-
2.03)
0.0 0.656
Venezuela 2 1,504 494 1,562 162 4.90 (3.24-
7.41)
70.4 0.066
Chile 2 129 73 691 197 13.7 (0.98-
191.4)
72.2 0.058
Peru´ 2 115 14 220 15 2.29 (0.95-
5.50)
0.0 0.478
Ecuador 1 154 62 186 15 7.68 (4.14-
14.26)
— —
Nicaragua 1 39 14 42 11 1.58 (0.61-
4.08)
— —
Primarily T. cruzi by country
T. cruzi I (Colombia, Mexico, Nicaragua and
Venezuela)
13 2,684 830 4,252 527 2.87 (1.88-
4.39)
84.6 0.000 0.373 0.549
T. cruzi II (Brazil) 19 7,360 3,280 11,191 3,156 2.82 (2.30-
3.46)
81.8 0.000
T. cruzi V (Argentina and Bolivia) 12 1,834 663 5,207 1,333 2.29 (1.60-
3.30)
82.4 0.000
Design
Cross-sectional 43 10,475 3,997 18,445 4,146 2.91(2.44-
3.47)
82.5 0.000 0.000 0.182
Cohort 6 1,801 925 3,302 1,098 2.01 (1.59-
2.54)
47.9 0.087
Area
Rural 22 5,890 2,160 9,793 2,282 2.92 (2.24-
3.80)
80.7 0.000 0.035 0.672
Urban 11 3,382 1,335 6,555 1,119 3.15 (2.40-
4.14)
84.1 0.000
Number of participants†
100 8 246 81 307 65 2.12 (1.38-
3.25)
6.7 0.378 0.410 0.701
101-1000 31 4,729 1,671 7,087 1,250 2.92 (2.34-
3.64)
76.0 0.000
1001 10 7,301 3,170 14,353 3,928 2.73 (2.06-
3.63)
93.1 0.000
(Continued)
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location, area, number of participants, number of tests used for diagnoses of CD, level of
adjustment and risk of bias (S4–S6 Tables).
Considering a P value of 0.10, rather than the conventional level of 0.05, is sometimes used
to determine statistical significance for heterogeneity, we investigated further the sources of
heterogeneity across our meta-analyses using a p-value lower than 0.10 as statistical significant.
When setting the p-value threshold to 0.10, the findings of meta-regression were similar as
when setting the p-value threshold of 0.05, except for the characteristics “location of the study”
which on p-value of 0.10, showed to contribute to heterogeneity of the meta-analysis for over-
all ECG abnormalities.
Table 1. (Continued)
Characteristics Number of
studies
Pooled ECG Abnormalities Heterogeneity p-value Cochran’s
Q
p-value
Meta-
regression
Total
CD
CAs in
CD
Total Non-
CD
CAs in Non-
CD
OR (95% CI) I2 (%) p-value
Age of participants
All ages 28 6,964 2,620 12,243 3,073 2.66 (2.13-
3.32)
81.0 0.000 0.433 0.704
 10 years 16 3,990 1,769 6,940 1,706 2.78 (2.08-
3.71)
85.9 0.000
Only children 3 597 222 1,772 344 3.88 (1.69-
8.88)
63.9 0.062
Sex
Women 6 1,104 356 2,863 813 2.51 (1.66-
3.81)
72.1 0.003 0.793 0.390
Men 6 893 336 2,213 603 3.77 (1.89-
7.50)
84.9 0.000
Definition of CAs
Specific definitions 40 10,355 4,137 17,130 4,015 2.95 (2.44-
3.57)
84.2 0.000 0.394 0.202
No-specified/no clear 9 1,921 785 4,617 1,229 2.44 (1.94-
3.08)
54.3 0.025
Test for the diagnoses CD
One test for CD 9 4,630 1,754 9,402 2,496 2.77 (1.90-
4.04)
91.4 0.000 0.006 0.970
More one test for CD 40 7,646 3,168 12,345 2,748 2.78 (2.33-
3.32)
76.4 0.000
Confounders adjustment‡
Yes 18 4,550 1,873 5,008 1,021 2.53 (2.14-
2.99)
40.2 0.040 0.419 0.370
No 31 7,726 3,049 16,739 4,222 2.97 (2.37-
3.73)
87.3 0.000
Risk of bias
High 11 1,910 514 1,932 179 3.31 (2.14-
5.10)
74.4 0.000 0.006 0.400
Medium 28 6,412 2,816 14,486 4,074 2.81 (2.24-
3.52)
85.3 0.000
Low 10 3,954 1,592 5,329 990 2.34 (1.79-
3.04)
71.6 0.000
p-value for heterogeneity was evaluated using random-effects meta-regression
†Total positive and negative for Chagas disease
‡Adjusted by confounders as age, sex and others in design
Abbreviations: CD=Chagas disease; CAs=ECG abnormalities; OR=Odds ratio.
https://doi.org/10.1371/journal.pntd.0006567.t001
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Publication bias
Under visual examination, funnel plots for studies assessing the general and specific prevalence
of ECG abnormalities were symmetrical, providing evidence for no publication bias. This was
further supported by the results of Egger’s test, showing no evidence of publication bias, either
graphically from the funnel plot, or quantitatively (p0.05 for Egger’s test asymmetry) (S7
Table and S30 Fig).
Discriminatory capacity of the ECG for diagnosis of CD
Finally, Sensitivity, specificity, PPV and NPV of general ECG abnormalities were 40.09%,
75.89%, 48.42% and 69.18%, respectively. PPV of specific ECG abnormalities for diagnosis of
CD varied, ranging between 61.64% and 83.08%, with two ECG abnormalities showing values
over 80%: complete RBBB (80.77%; 95%CIs=78.17-83.13) and the combination of complete
RBBB and LAFB (83.08%; 95%CIs= 77.36-87.59) (S8 Table).
Discussion
We systematically reviewed the current evidence for the prevalence of overall and specific
ECG abnormalities in CD individuals in the general population. Overall, we found that sub-
jects with CD, compared to non-CD participants, have almost a threefold higher prevalence of
ECG alterations. Namely, a higher prevalence of complete RBBB, LAFB, first degree AV-B,
VE, combined AF and flutter and, the combination of RBBB and LAFB, whereas no difference
Table 2. Meta-analysis of specified ECG abnormalities in CD and Non-CD.
Specified ECG
abnormalities
Number of studies Pooled specified ECG abnormalities Heterogeneity p-value Cochran’s Q
Total CD Events CD Total Non-CD Events Non-CD OR (95% CI) I2 (%) p-value
Ventricular conduction defects
Incomplete RBBB 19 2,383 269 3,242 394 0.85 (0.63-1.16) 33.8 0.076 0.316
Complete RBBB 24 2,636 710 3,360 169 4.60 (2.97-7.11) 64.5 0.000 0.000
Incomplete LBBB 3 691 27 827 56 0.63 (0.39-1.01) 0.0 0.929 0.055
Complete LBBB 8 1,579 37 2,325 38 0.99 (0.62
-1.58)
19.1 0.278 0.958
LAFB 30 3,919 734 4,040 419 1.60 (1.21-2.13) 54.1 0.000 0.000
LPFB 7 1,317 9 1,002 12 0.96 (0.35-2.62) 6.9 0.375 0.933
Complete RBBB+LAFB 15 1,891 167 1,608 34 3.34 (1.76-6.35) 35.9 0.082 0.000
Atrioventricular block
The first AV-B 21 3,112 161 3,457 77 1.71 (1.25-2.33) 10.9 0.317 0.001
Second degree AV-B 7 1,177 7 2,117 1 1.15 (0.33-4.06) 0.0 0.665 0.822
Third degree AV-B 5 1,275 9 2,176 2 2.10 (0.60-7.34) 0.0 0.923 0.246
Arrhythmias
Atrial fibrillation 11 2,075 44 2,871 22 1.55 (0.86-2.78) 0.0 0.862 0.141
Atrial fibrillation or flutter 13 2,654 78 3,750 40 2.11 (1.40-3.19) 0.0 0.789 0.000
Ventricular extrasystoles 25 3,142 588 3,749 366 1.62 (1.14-2.30) 59.5 0.000 0.000
Supraventricular
extrasystoles
12 2,004 73 2,525 91 1.14 (0.82-1.59) 2.8 0.417 0.428
Other
Low voltage QRS 10 2,426 45 3,149 79 0.84 (0.47-1.50) 28.6 0.181 0.421
Abbreviations: ECG=Electrocardiogram; CD=Chagas disease; OR=Odds ratio; RBBB=Right bundle branch block; LBBB=Left bundle branch block; LAFB=Left
anterior fascicular block; LPFB=Left posterior fascicular block; AV-B=Atrioventricular block.
https://doi.org/10.1371/journal.pntd.0006567.t002
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in other ECG abnormalities were observed between CD and non-CD participants. Also, preva-
lence of ECG alterations in children was similar to that in adults and suggests earlier onset of
cardiac disease.
The current study complements and extends findings from a previous systematic review
[37] that reported higher prevalence of RBBB and LAFB but no difference in AF in CD partici-
pants compared to non-CD participants. However, our review included 34,023 vs. 17,238 par-
ticipants more with an additional 19 papers (49 vs. 30 studies), overlapping only on 10 studies
(20.4%) with the previous review. Further, contrary to the current effort the previous work
included clinical and community cases, with controls being mainly from the general popula-
tion, whereas our study included only population-based studies comparing ECG alterations
compatible with CD in seropositive and seronegative subjects recruited from the non-clinical
setting. Studies using cases from a clinical setting and controls from the general population,
including the mentioned systematic review, tend to overestimate the prevalence of ECG alter-
ations. Furthermore, Cardoso et al.[37] found no data available to calculate prevalence of 1st
and 2nd degree AV-B in CD and non-CD individuals, whereas our study quantified the preva-
lence of these ECG alterations, documenting a higher prevalence of first degree AV-B block.
Our findings further extend previous reports by providing the prevalence of overall and spe-
cific ECG alterations, reporting a higher prevalence of combined AF/flutter and VE among
Fig 3. Prevalence of overall and specified ECG abnormalities in CD to compared non-CD participants. Forresplot determined the association
between overall and specified ECG abnormalities with CD to compared Non-CD participants. Abbreviations: CD=Chagas disease; RBBB=Right
bundle branch block; LAFB=Left anterior fascicular block; AV-B=Atrioventricular block.
https://doi.org/10.1371/journal.pntd.0006567.g003
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CD compared to non-CD participants. In contrast, no differences in incomplete and complete
LBBB, LPFB, second and third degree AV-B, supraventricular extrasystoles and low voltage
QRS were observed.
Finally, even though childhood heart involvement is an uncommon event and cardiac alter-
ations are considered to take decades to ensue in adults with T. cruzi infection[38–40], our
data indicates that CD is associated with a higher prevalence of ECG alterations both in chil-
dren and adults. Also, our findings on high frequency of ECG alterations in children (5-13
years) suggest earlier manifestations of anomalies progression when T. cruzi infection is
acquired at a younger age [38, 41, 42]. A previous clinicopathologic study based on medical
records and autopsies, carried out in 19 children and adolescents (6-17 years) determined a
prevalence of ventricular premature contractions 58%, LAFB 45%, first degree A-V block 28%,
complete RBBB 11%, AF 11%; the authors concluded that, in this adolescent population, CD
shows relevant peculiarities, like rapid evolution toward decease (as short as 128 days), diagno-
sis difficulty related to occurrence of mitral regurgitation (61% wrong initial diagnosis) and
low RBBB frequency, suggesting that CD at this age range can be of a peculiar type, making
clarification of the pathogenic mechanism of chronic CD in teens useful to pinpoint the patho-
genic mechanism of the disease[43].
Although the etiology of cardiac alterations in CD-patients remains unclear, a number of
biologically plausible mechanisms have been suggested. Cardiac alterations are characterized
by development of a diffuse cellular infiltrate, microcirculation alterations that lead to fibro-
sis[44]. Evidence suggests that low grade parasite persistence triggers a parasite-specific
immune response to T. cruzi in the heart, and that at least some of the cells comprising the
infiltrate are parasite-specific[44]. Simões-Barbosa et al. reported that T. cruzi infection may
affect gene expression in human host cells via LINE-1 retrotransposon, which may play an
important role in the pathogenesis of CD cardiac involvement[45, 46]. T. cruzi infection also
impairs parasympathetic innervations predisposing to sympathetic over-activation which
may lead to further cardiac damage and arrhythmogenesis[47, 48]. T. cruzi persistence may
directly initiate vascular endothelial cell damage or lead to microvasculature damage via its
effects on the inflammatory infiltrate as well as on several bioactive lipids such as thrombox-
ane A and prostaglandin F2α, potent vasoconstrictors[44]. In summary, multiple mecha-
nisms may be responsible for the development of cardiac alterations in individuals infected
with T. cruzi that include host and specific parasite characteristics that need further
investigation.
There were several strengths and limitations of the present study. Our analysis included
more than 34,023 seropositive and seronegative CD participants, and investigated a wide
range of ECG abnormalities. We also included only studies based on subjects recruited
through community surveys and blood bank screening (population-based), in order to avoid
overestimation of effect measures that may arise by inclusion of clinical populations. As with
all systematic reviews we are prone to publication bias. However, there was little evidence of
publication bias, and therefore, the likelihood that studies with negative findings are not pub-
lished is low. We performed an extensive search strategy in several databases in order to iden-
tify all relevant studies in the topic. Nevertheless, since majority of studies were from Latin
America, and we did not use terms in Portuguese and Spanish language in our search, we do
not exclude the possibility to have missed some relevant studies. However, the search strategy
we used included the term “Chagas” that has no translation, so we believe that it did not intro-
duce selection bias or if it did, it would be minor. Additionally, the low and moderate quality
of the individual published studies included in this meta-analysis was limited. Variation in
study regarding inclusion and exclusion criteria and the diverse populations included in differ-
ent studies, contributed to the heterogeneity of findings noted in several of the meta-analyses
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performed. Other sources of heterogeneity are likely to include different diagnostic methods
for CD, and variation in the criteria applied for the definition of ECG abnormalities. However,
we did not observe any heterogeneity in 5 out of 16 meta-analyses, as well as in the meta-analy-
sis based only on children.
The cardiac manifestations in T. cruzi infected subjects, documented by the presence of spe-
cific ECG changes such as complete RBBB and LAFB in its initial stages. As disease advances,
AV-B, VE and atrial fibrillation/flutter may ensue[49, 50]. These findings may be relevant for
diagnostic and epidemiologic purposes as once cardiac alterations are established the progno-
sis of these subjects might deteriorate rapidly. These findings may have important implications
for non-endemic countries, where the prevalence of CD in Latin-American migrants is 4.2%
(95% CIs=2.2-6.7%)[6], in which less than 1% of the expected prevalence of CD-cardiomyopa-
thy has been reported, suggesting under diagnosis and suboptimal physician awareness[51].
Specific ECG alterations such as RBBB associated with LAFB, AV-B, atrial fibrillation/flutter
and VE, should alert the clinician encountering patients with heart failure or cardiomyopathy
of unknown etiology originally form Chagas endemic regions, to consider obtaining serologic
tests to rule out T. cruzi infection[30]. Finally, the increased prevalence of ECG abnormalities
in children underscores the need for early diagnosis and trypanocidal treatment should be
considered.
CD is recognized by World Health Organization as a neglected tropical disease that histori-
cally, has not received sufficient public health interest, or research and governmental resources
worldwide. CD costs in Latin America are estimated up to 662,000 disability-adjusted life-
years of productivity as of 2008, and the total economic toll attributed to the disease each year
is estimated at over $7 billion USD, with more than 10% of this cost being incurred in the
United States and Canada. Eminent scientists have labeled Chagas Disease as ‘‘The New HIV/
AIDS of the Americas’’, and 20–30% of people infected with Chagas disease will develop
potentially fatal cardiomyopathy in their lifetime. Yet, there is no vaccine or highly effective
medical treatment available for the approximately 10 million people currently infected with T.
cruzi [52].
In terms of public health, our findings provide an update and synthesis of the burden of car-
diac disease in Chagas patients, and complement previous findings on excesses mortality in
this individuals. Cucunuba ZM et al. [40] showed that excess mortality exists in CD, both in
symptomatic and asymptomatic populations. In addition, our results provide important data
that could be useful for futures studies to better estimate the health and economic burden of
CD in Latinamerica. Understanding morbidity and mortality in Chagas patients at population
level as shown in this study, provides a better understanding of the disease burden and impact,
and highlights the need for better detection, diagnosis, treatment and management of affected
populations. Improved morbid-mortality Chagas disease estimates at population level will
serve to highlight the real need for better detection, diagnostics, treatment and management of
affected populations[14].
Conclusion
This systematic review and meta-analysis provides an update and synthesis in this field. This
research of observational studies indicates a significant excess in prevalence of ECG abnormal-
ities (40.1%) related to T. cruzi infection in the general population from Chagas endemic
regions, being the most common ventricular (RBBB and LAFB), and A-V B (first-degree)
node conduction abnormalities as well as arrhythmias (AF or flutter and VE). Also, prevalence
of ECG alterations in children was similar to that in adults and suggests earlier onset of cardiac
disease.
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